Paper Details
- Home
- Paper Details
Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: A double-blind, randomized, vehicle-controlled trial.
Author: BaresJennifer, BaumDanielle, ChenTinley, ChimaMargot, GagliottiMatthew, GeneceJordan, HashimPeter W, KimHee J, KimmelGrace W, LebwohlMark G, NiaJohn K, SingerGiselle, YaoChristopher J
Original Abstract of the Article :
BACKGROUND: Psoriasis of the intertriginous, anogenital, and facial regions remains a therapeutic challenge, with current algorithms lacking a topical agent that exhibits both high efficacy and minimal side effects. OBJECTIVE: To assess the safety and efficacy of crisaborole 2% ointment-a nonsteroi...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1016/j.jaad.2019.06.1288
データ提供：米国国立医学図書館（NLM）
A Topical Treatment for Psoriasis: Crisaborole 2% Ointment
Psoriasis is a [Chronic skin condition] that affects millions of people. This study investigates the effectiveness of [Crisaborole 2% ointment] as a [Topical treatment] for [Psoriasis of the intertriginous, anogenital, and facial regions]. This [Double-blind, randomized, vehicle-controlled trial] aimed to assess the [Safety and efficacy] of [Crisaborole 2% ointment] in treating these challenging areas. The study found that [Crisaborole 2% ointment] led to [Significant improvement] in [Psoriasis severity] and was well-tolerated, with [No adverse events] reported. This study offers a [Promising treatment option] for individuals with [Psoriasis] in difficult-to-treat areas.
A New Oasis in the Desert of Psoriasis Treatment: Crisaborole 2% Ointment
This study provides a [Breath of fresh air] in the [Desert of psoriasis treatment]. The researchers discovered that [Crisaborole 2% ointment] is a [Effective and well-tolerated] treatment for [Psoriasis] in [Difficult-to-treat areas]. The [Significant improvement in psoriasis severity] observed in the study is a testament to the [Potential] of this [Topical agent] to [Improve the lives] of individuals with [Psoriasis].
Treating Psoriasis: A Holistic Approach
This study reminds us that [Treating psoriasis] requires a [Multifaceted approach]. While [Topical treatments] are an essential part of [Managing the condition], [Holistic therapies] such as [Stress management and lifestyle modifications] can also play a significant role in [Improving overall health and well-being]. This research provides a [valuable tool] for doctors and patients to [Develop a personalized treatment plan] that meets their specific needs and goals.
Dr.Camel's Conclusion
This double-blind, randomized, vehicle-controlled trial demonstrates the safety and efficacy of crisaborole 2% ointment in treating psoriasis in difficult-to-treat areas, offering a promising treatment option for individuals with this chronic skin condition. The study underscores the importance of personalized treatment plans and holistic approaches to managing psoriasis for optimal health outcomes.
Date :
- Date Completed 2020-08-20
- Date Revised 2020-08-20
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.